If anybody reads the trial postings on clinicaltrial.gov, here's how ATL is listed:
"Active Comparator: Group B (placebo, ATL-DC, poly ICLC)" It is by no means a standard of care as that requires actually being commercially approved and in common use by medical professionals for the treatment of the condition. DCVax-L is certainly NOT that.
Market Data 
Markets 
